Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130194 · ClinicalTrials.gov registry record · Phase 2
Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma
A Phase 2 study, sponsored by St. Louis University.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT01130194: Completed Phase 2 study, sponsored by St. Louis University.
NCT01130194 is a Phase 2 study that has completed, run by St. Louis University. The registered enrollment target is 29 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01130194, a Phase 2 study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
Follicular lymphoma has historically been considered an incurable lymphoma. By combining multiple effective treatments, the investigators believe that prolonged disease-free survival is achievable in this disease. The investigators goal is to have at least 60-70% of our patients in first continuous complete remission 15 years from initiation of treatment.
Interventions
- OTHER Combination of treatment modalities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-07 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
What the finished NCT01130194 record still lists
NCT01130194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Combination of treatment modalities is the first listed.
NCT01130194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01130194 about?
NCT01130194 is a clinical study titled "Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma". Follicular lymphoma has historically been considered an incurable lymphoma. By combining multiple effective treatments, the investigators believe that prolonged disease-free survival is achievable in this disease. The investigators goal is to have at least 60-70% of our patients in first continuous ...
What is the current status of trial NCT01130194?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2006-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01130194?
The interventions under investigation include: Combination of treatment modalities (OTHER).
Who is sponsoring clinical trial NCT01130194?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01130194's enrollment target sits among peer trials
29 1669th of 2000 higher than 324 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia